|
Market Closed -
Nasdaq
16:00:00 2026-10-08 EDT
|
5-day change | 1st Jan Change | ||
| 1.220 USD | -2.40% |
|
-5.43% | -26.51% |
| 10-06 | SNDL Inc. Announces Resignation of Carlo Cannell as Director, Effective October 06, 2026 | CI |
| 07-28 | SNDL Shares Fall After Q2 Swings to Adjusted Operating Loss, Revenue Declines | MT |
| Market Cap | 432M 304M 271M 253M 230M 29.38B 436M 3.03B 1.18B 14.99B 1.14B 1.12B 47.95B | P/E 2026 * |
-20.4x | P/E 2027 * | 174x |
|---|---|---|---|---|---|
| Enterprise Value | 432M 304M 271M 253M 230M 29.38B 436M 3.03B 1.18B 14.99B 1.14B 1.12B 47.95B | EV / Sales 2026 * |
0.48x | EV / Sales 2027 * | 0.47x |
| Free-Float |
98.31% | Yield 2026 * |
-
| Yield 2027 * | - |
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| SNDL | Delayed | |
CBOE
| SNDL | Real-time | |
|
Canadian Securities Exchange
| SNDL | Delayed | |
|
Tradegate
| VY4 | Real-time | |
|
Deutsche Boerse AG
| VY4 | Delayed | |
|
Börse Stuttgart
| VY4 | Delayed | |
|
Boerse Muenchen
| VY4 | Real-time |
Last Transcript: SNDL Inc.
| 1 day | -2.40% | ||
| 1 week | -5.43% | ||
| Current month | -5.43% | ||
| 1 month | -14.98% | ||
| 3 months | -6.15% | ||
| 6 months | -6.87% | ||
| Current year | -26.51% |
| 1 week | 1.21 |  | 1.28 |
| 1 month | 1.21 | | 1.44 |
| Current year | 1.16 | | 1.82 |
| 1 year | 1.16 | | 2.89 |
| 3 years | 1.15 | | 2.93 |
| 5 years | 1.15 | | 9.6 |
| 10 years | 1.15 | | 132.2 |
| Manager | Title | Age | Since |
|---|---|---|---|
Zachary George
CEO | Chief Executive Officer | 48 | 2020-01-29 |
| Director of Finance/CFO | 53 | 2023-06-30 | |
Phil McBride
CTO | Chief Tech/Sci/R&D Officer | 52 | 2024-11-20 |
| Director | Title | Age | Since |
|---|---|---|---|
Gregory Turnbull
BRD | Director/Board Member | 71 | 2018-09-30 |
Greg Mills
CHM | Chairman | 63 | 2019-05-31 |
Zachary George
BRD | Director/Board Member | 48 | 2019-11-26 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 9/16/26 | Option | Director | 29,939 | 0.0121% | ||
| 9/16/26 | Option | Chairman | 38,256 | 0.0154% | ||
| 9/16/26 | Option | Director | 14,970 | 0.0060% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.40% | -5.43% | -53.96% | -27.81% | 311M | |
| -1.61% | +1.08% | +38.64% | +106.93% | 1,060B | |
| -0.76% | -3.12% | +35.78% | +62.70% | 623B | |
| +0.39% | +4.14% | +17.00% | +83.77% | 480B | |
| -0.29% | -2.02% | +62.52% | +37.06% | 352B | |
| -2.03% | +1.03% | +22.25% | +42.16% | 345B | |
| -1.92% | -1.87% | +11.94% | +33.20% | 274B | |
| -2.36% | -3.16% | -6.95% | +8.68% | 249B | |
| -1.37% | -3.34% | +37.86% | +52.33% | 223B | |
| +0.17% | -1.31% | +25.96% | +96.82% | 182B | |
| Average | -1.34% | -0.75% | +19.11% | +49.58% | 378.83B | |
| Weighted average by Cap. | -0.87% | +0.04% | +30.56% | +68.81% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 909M 639M 570M 532M 483M 61.84B 919M 6.37B 2.49B 31.55B 2.4B 2.35B 101B | 925M 650M 580M 540M 491M 62.88B 934M 6.48B 2.53B 32.08B 2.44B 2.39B 103B |
| Net income | -21.59M -15.17M -13.53M -12.62M -11.47M -1.47B -21.81M -151M -59.07M -749M -56.96M -55.74M -2.4B | 2.1M 1.48M 1.32M 1.23M 1.12M 143M 2.12M 14.71M 5.74M 72.84M 5.54M 5.42M 233M |
| Net Debt | - | - |
Employees
2,751
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-08 | US$1.220 | -2.40% | 1,386,281 |
| 26-10-07 | US$1.250 | +1.63% | 1,257,375 |
| 26-10-06 | US$1.230 | -1.60% | 1,384,042 |
| 26-10-05 | US$1.250 | +0.81% | 1,217,262 |
| 26-10-02 | US$1.240 | -1.59% | 1,216,799 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
1.783CAD
Average target price
4.932CAD
Spread / Average Target
+176.68%
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- SNDL Stock
Select your edition
All financial news and data tailored to specific country editions
